此外,研究作者发现:每服用避孕药5年,患最致命的卵巢癌的可能性就会降低32%。
"We have known for a long time that women who use oral contraceptives are at lower risk of ovarian cancer in general. What was not known relates to the question if this protective effect also applies to women with highly fatal disease," Kirsten Moysich, PhD, distinguished professor of oncology at Roswell Park Comprehensive Cancer Center and the senior author of this study, tells Health.
"我们早已知晓:服用口服避孕药的女性患卵巢癌的风险较低。但我们并不清楚,对于患有致命疾病的女性而言,避孕药是否仍能起到这一保护作用,"罗斯威尔公园综合癌症中心的肿瘤学杰出教授柯尔斯顿·莫伊西斯博士对《健康》杂志说道,她也是本研究的资深作者。
According to a statement published by Roswell Park, Moysich's team pooled data from 20 case-control studies. These studies involved 579 patients who died within 12 months of being diagnosed with ovarian cancer, matched to a control group of 2,279 patients who did not have ovarian cancer.
据罗斯威尔公园综合癌症中心发布的一份声明表示,莫伊西斯团队汇集了20项案例的对照研究数据。这些研究涉及579名患者,她们在诊断出卵巢癌后的12个月内去世,同时,对照组是2279位非卵巢癌患者
Ovarian cancer is the fifth leading cause of cancer deaths in the United States, according to the American Cancer Society. In 2019, about 22,530 women will receive a diagnosis of ovarian cancer, and about 13,980 will die from the disease.
【避孕药或有助于降低患卵巢癌的风险】相关文章:
★ “过劳”被世卫组织列入疾病分类 你身边有这样的“病人” 吗?
★ 男性避孕药出来了
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15